Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Cooper

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Nature Plants|April 26, 2024
A sweet victory for sugarcane genomicsElizabeth A Cooper
Skin Therapy Letter|February 4, 2021
Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim AnalysisAditya K Gupta, Elizabeth A Cooper
Mycopathologia|May 15, 2008
Update in antifungal therapy of dermatophytosisAditya K Gupta, Elizabeth A Cooper
Journal of Fungi (Basel, Switzerland)|September 27, 2024
Extended Use of Topical Efinaconazole Remains Safe and Can Provide Continuing Benefits for Dermatophyte Toenail OnychomycosisAditya K Gupta, Elizabeth A Cooper
Journal of Cutaneous Medicine and Surgery|October 6, 2009
Psoriatic nail disease: quality of life and treatmentAditya K Gupta, Elizabeth A Cooper
Infectious Disease Reports|January 23, 2025
Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent UseAditya K Gupta, Elizabeth A Cooper
Molecular Ecology|April 4, 2017
Genomic evidence for convergent evolution of a key trait underlying divergence in island birdsElizabeth A Cooper, J Albert C Uy
Journal of Cutaneous Medicine and Surgery|May 16, 2013
Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazoleAditya K Gupta, Elizabeth A Cooper, Maryse Paquet
Skin Health and Disease|December 3, 2024
Safety and efficacy of the swift microwave device in patients with mild-to-moderate onychomycosis: Protocol of an open-label, randomized, dose-finding pilot studyAditya K Gupta, Elizabeth A Cooper, Tong Wang
Skinmed|December 9, 2010
Zyclara (imiquimod) cream, 3.75%Aditya K Gupta, Elizabeth A Cooper, William Abramovits
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Nature Plants|April 26, 2024
A sweet victory for sugarcane genomicsElizabeth A Cooper
Skin Therapy Letter|February 4, 2021
Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim AnalysisAditya K Gupta, Elizabeth A Cooper
Mycopathologia|May 15, 2008
Update in antifungal therapy of dermatophytosisAditya K Gupta, Elizabeth A Cooper
Journal of Fungi (Basel, Switzerland)|September 27, 2024
Extended Use of Topical Efinaconazole Remains Safe and Can Provide Continuing Benefits for Dermatophyte Toenail OnychomycosisAditya K Gupta, Elizabeth A Cooper
Journal of Cutaneous Medicine and Surgery|October 6, 2009
Psoriatic nail disease: quality of life and treatmentAditya K Gupta, Elizabeth A Cooper
Infectious Disease Reports|January 23, 2025
Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent UseAditya K Gupta, Elizabeth A Cooper
Molecular Ecology|April 4, 2017
Genomic evidence for convergent evolution of a key trait underlying divergence in island birdsElizabeth A Cooper, J Albert C Uy
Journal of Cutaneous Medicine and Surgery|May 16, 2013
Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazoleAditya K Gupta, Elizabeth A Cooper, Maryse Paquet
Skin Health and Disease|December 3, 2024
Safety and efficacy of the swift microwave device in patients with mild-to-moderate onychomycosis: Protocol of an open-label, randomized, dose-finding pilot studyAditya K Gupta, Elizabeth A Cooper, Tong Wang
Skinmed|December 9, 2010
Zyclara (imiquimod) cream, 3.75%Aditya K Gupta, Elizabeth A Cooper, William Abramovits
Pageof 7